Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (48)

« Back to Publications

Development of clinical immunity to Plasmodium vivax following repeat controlled human malaria infection

Hou MM. et al, (2025), Nature Communications, 16

Plasmodium falciparum infection induces T cell tolerance that is associated with decreased disease severity upon re-infection

Muñoz Sandoval D. et al, (2025), Journal of Experimental Medicine, 222

High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response

Mentzer AJ. et al, (2024), Nature Medicine, 30, 1384 - 1394

A systematic analysis of the human immune response to Plasmodium vivax

Bach FA. et al, (2023), Journal of Clinical Investigation, 133

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection

Hou MM. et al, (2023), Science Translational Medicine, 15

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

Mentzer AJ. et al, (2023), Nature Medicine, 29, 147 - 157

Impact of a blood-stage vaccine on Plasmodium vivax malaria

Hou MM. et al, (2022)

Controlled human malaria infection with a clone of Plasmodium vivax with high-quality genome assembly

Minassian AM. et al, (2021), JCI Insight, 6

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2021), Nature Medicine, 27, 1113 - 1113

Mapping immune variation and var gene switching in naive hosts infected with Plasmodium falciparum

Milne K. et al, (2021), eLife, 10

Publisher Correction: ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

van Doremalen N. et al, (2021), Nature, 590, E24 - E24

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques

van Doremalen N. et al, (2020), Nature, 586, 578 - 582

A single dose of ChAdOx1 MERS provides protective immunity in rhesus macaques

van Doremalen N. et al, (2020), Science Advances, 6

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine

Folegatti PM. et al, (2019), Vaccines, 7, 40 - 40

Load More